Failure Flashcards

1
Q

Define heart failure

A

Pathophysiological state in which the heart is incapable of pumping sufficient supply of blood to meet the metabolic requirement of the body, or requires elevated ventricular pressures to achieve the same.

Failing heart may still maintain perfusion via frank starling mechanisms- low filling volume hypoperfusion indicates pump-priming probe distinct from cardiac disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Briefly define diastolic and systolic heart failure

A

Systolic failure is defined as failure with EF >40%
Diastolic failure or EF preserved failure is a pathological condtiion with normal or near normal EF with failure of ventricular relaxation and consequent high filling pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss the 4 categories of heart failure as per the ASA

A

1) patients at risk of developing failure
2) asymptomatic LV dysfunction
3) symptomatic HF
4) refractory HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List predisposing factors to the development of Heart failure

A

HTN, atherosclerosis, DM, tobacco use, dyslipidaemia, obesity cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss frank starling mechanisms

A

Within physiological limits force of ventricular contraction is directly related to end disatolic length of the myofibril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss factors affecting heart contractility

A

Physiological depressants

  • acidosis
  • hypercarbia
  • hypoxia
  • ishcaemia

Pharmacological agents

  • B blockade
  • CA blocker
  • antiarythmic agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Discuss preload

A

The amount of force stretching the myofibril before contraction

Optimal preload stretches the myofibrils to the fullest and leads to the most forceful contraciotn

The risk of pulmonary oedema increases when LV end diastolic pressure rises significantly above normal ranges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Discuss afterload

A

Pressure against which the heart must pump to eject blood.
Afterload represent the mural tensions on myocardial cells during contraction and is determined by the TPVR and the cardiac chamber size

BP is determined by the product of CO and SVR

HTN is a major contributor to heart failure. Those in failure tend to maintain their blood pressure through peripheral vasoconstriction mediated mainly by endogenous catecholamines and teh RAAS

Failing ventricles have difficulty overcoming increases in peripheral resistance instead dilating further increasing end diastolci volume to maintain SV even with decreasing EF –they are therfore extremely afterload dependant and modest vasodilation can dramatically increase cardiac ouptut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Discuss cardiac output

A

CO = HR *SV

CO increase to a heart rate of about 160 above this diastolic filling time is compromised leading to decreased cardaic output and coronary artery perfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss increase in SV, SVR and development of cardiac

A

Increase in SV occurs in response to increase in preload it i prompt and effective in improving CO in response to acute demands. Its response is limited however because myofibril stretch to a sarcomere length beyond 2.2um does not increase stroke output and may reduce it

Increase in SVR results in redistribution of a subnormal CO away from skin and skeletal muscle and kidneys to maintain normal blood flow to the brain and heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss cardiac hypertrophy as a compensatory mechanisms

A

LV remodeling describes the changes in ventricular mass volume, shape and composition in response to mechanical stress and systemic neurohormonal activity.

Development of cardiac hypertrophy is the primary chronic adaptation of the heart to compensate for pump failure.

Hypertrophy predominates increasing the number of myofibrils per cell as the heart has a very limited abilities to produce new cells. New myofibrils arrange in series in response to an increase in chamber volume (leading to dilation) and in parallel when responding to higher pressures ( leading to increase in wall thickness). Mitochondrial mass also expands leading to an increase in availablility of ATP- mitochondrial dysfunciton is well recongnised in failure.

Initially these changes lead to improved function of each cell but at a higher energy cost.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the cardiac neurohormonal response

A

Increase in myocardial wall stretch activate and release cardiac natriuretic peptides. These including c type and b type natriuretic peptide.

These peptides promote water and sodium excretion increase peripheral vasodilation and inhibit the RAAS. In early failure they play a key role in compensation for LV dysfucntion. Attenuation of renal response to these peptides occur as failure progresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss the CNS and ANS neurohormonal response to failure

A

The heart and great vessels contain sensory receptors that detect changes in perfusion.
ADH is release from the pituitary gland in response to decreases in perfusion – this increases intravascular volume and decrease osmolality

Failure in general leads to activation of the sympathetic and inactivation of the parasympthetic systems

Chronically a decrease in the number and affinity of surface catecholamines occur in the myocardial tissues reducing responsiveness to norad and adrenaline - elevated catecholamine’s adversly affect myocardial perfusion leading to progressive cardiac cell death and fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss renal neurohormonal response

A

Decreased glomerular perfusion results in reducced renal excreation of sodium causing renal arteriolar and adrenergic receptors to stimulate renin release and active RAS +aldosterone

Renal adaptation to hypoperfusion occurs mainly through production of vasodilatory hormones such as prostacyclin along with PGI2 and PGE2 – Nsaids inhibit this by interfering with COX therefore except for there useful antiplatlet effect they should be avoided in patient with chronic heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss vascular endothelial neurohormonal response

A

Endothelial function locally regulates vasomotor tone. Endothelins are produced by endothelial and smooth muscle cells as well as neural renal pulmonary and inflammatory cells.

This occurs in response to HD stress, hypoxia, catecholamines, angiotensin 2 and many inflammatory cytokines.

NO is almost universally produced by all tissues. Reduced synthesis or increased degradation at the endothelial level is detrimental to heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss maladapative changes in heart failure

A

Ventricular remodeling includes cardiac dilation, reactive hypertrophy, progressive fibrosis and changes in wall conformation.

Reverse remodeling is a concept in which progressive LV dysfunction is not simply arrested but also partially reversed

Various antihypertensive therapies inclduing B blockade, ACE, ARBs and alodseterone antaognist allow regression of LV hypertrophy and reducen the rate of sudden death.,

17
Q

List Aetiology of reduced ejection failure

A
  • Ischaemic heart disease – dominant cause of HF in developed countries
  • Valvular disease - aortic stenosis
  • Cardiomyopathy (alcoholic, thyroidtoxic, HOCM)
  • HTN
  • Arrhythmuias and conduction system disease
18
Q

Discuss mechanisms that lead to diastolic or EF preserved dysfunction List Aetiology of EF preserved failure

A

1) imparied ventricular relaxation
2) increased ventricular wall thickness
3) accumulation of myocardial interstitial collagen

Impaired lusitropy of the myocardium leads to higher ventricular filling pressure reuslting in congetive symptoms. Relaxation is an active energy requiring process.

DDX of HFpEF
Cardiomyopathies with preserved EF
- Restrictive
—– familial ( amyloidosis, fabry disease, familial causes of iron overload)
—– nonfamilial ( Systemic sclerosis, carcinoid heart disease, metastatic cancer, radiation)
- Hypertrophic
—–Familial

Vavular heart disease

  • Mitral stenosis or regurg
  • aortic regurg

Right heart failure

  • pulmonary HTN
  • Right ventricular infarct
  • ARVD

Pericardial dsiase

  • cardiac tamponade
  • constrictive pericardtiis
  • effusive constrictive pericardial disease

Obstructive lesion in heart or great vessel

  • atrial myxoma
  • pulmonary vein stenosis

Highoutput heart failrue

19
Q

Discuss right vs left failure

A

somewhat artificial term and unless failure is of acute aetiology (MI) will happen in concert.

Part of the same circuit and output of the two sides must be equal. Also share a ventricular wall failure in one side leads to bowing of the septum to the other ventricle leading to reduced filling and reduced CO

20
Q

Discuss high output failure vs low output failure

A

High output refers to a hyperdynamic state with supernormal cardiac output, lowered PVR and low AV o2 difference (decreased o2 extraction ratio) -results in borderline preserved or depressed systemic arterial blood pressure and elevated cardiac filling pressures - this leads to activation of RAS and increase in salt and water retention – chronci volume overload leads to ventricular enlargement and failure

Aetiology
-Increased preload (sodium retention or excess mineralocorticoids)

-reduced SVR (pregnancy, av fistula, chirrhosis, severe anaemia, thyrotoxicosis, pagets disease)

  • increased sympathetic activity
  • persistent tachycardia

Myocardial and reduced vascular effect

  • sepsis
  • beriberi
  • acromegaly

Recognition of these states early allows for treatment of undelrying cause and may prevent development of heart failrue
Persistence of a hyper dynamic state leads to cardiac damage

Low output states is the classical heart failure

21
Q

List common precipitating causes of acute heart failure

A
  • Sodium or volume excess
  • PE
  • MI
  • HTN
  • Systemic infection
  • dysrhthmias
  • pregnancny
  • anaemia
  • thyrotoxicosis
  • acute mycocarditis
  • valvular pathology
  • sympathomimeitic or acohol excess
  • excessive exertion or truama
  • pharm
22
Q

Discuss clinical features of heart failure

A
  • dyspnoea
  • chest pain
  • previous heart disease
  • catheterization
  • current meds and adherance to the same
  • PND is caused from pulmonary congestion precipitated by plasm volume expansion that occurs during recumbencey because intersitial oedema is reabsorbed into the circulation
  • Orthopnoea occurs via the same mechanisms

Most patient with ACPE are dipahoretic because of intense sympathetic activation.

Clinical finding

  • wheeze
  • creps
  • positive response to bronchodilator therapy does not exclude heart failure
  • raised JVP
  • S3 gallop
  • peripheral oedema
23
Q

Discuss DDX of cardiac failrue

A
Normal present with respiratory copromise 
-non cardiac APO 
-PE
-Pneumonia 
-COPD 
- pneumothorax
0 cardiac tamponade
- anaphylaxis
24
Q

Discuss IX

A

Bloods - FBC - anaemia , U&E for electrolytes, renal function, BNP, TNI
CXR - exlude multiple DDX
Bedside ultrasound

25
Q

Discuss NYHA functional classes of CCF

A

1) asymptomatic on ordinary physical activity
2) symptomatic on ordinary physical activity
3) symptomatic on less than ordinary physical activiy
4) symptomatic at rest

26
Q

Discuss general approach to management of acute heart failure

A

Three tenants

1) determining the underlying cardiac pathology
2) identify the precipitant
3) mitgate decompensation

Primary treatment goals are to improve respiratory gas exchange, maintain adequate arterial saturation and decrease LV diastolic pressure while maintaining adequate cardaic and systemic perfusion

Acute congestive state can be managed by

1) reducing cardiac workload through decreased preload and afterload
2) reducing excessive retention of salt and water
3) improving cardiac contractility

27
Q

Discuss management of acute heart failure with adequate perfusion

A

Many patient with failure demonstrate adequate systemic perfusion with elevated BP and this indicates presence of considerable mycoardail reserve and is associated with lower mortality in both acute and chornic HF.

Treatment should involve reduction in both preload and afterload.
Therapy should being with upright positioning of the patient, supplemental oxygen, nitrates, morphine and loop diuretics

Ventilation and oxygenation

  • Most patient will have hypoxemia and need high flow oxygen if o2 below 90%- hyperoxemia is detrimental as it may significantly increase afterload and worsen cardiac function in decompensated failure.
  • NIV increases functional residual capacity, improves o2, reduces work of breathing and resutls in decreased LV preload and fterload by raising intrathoracic pressures. BiPAP further reduced work of breathing and more readily improves hypercarbia than CPAP alone.
  • if unable to tolerate bipap intubate

Nitrates

  • start at initial dose of 5-10mic/min IV increasing in 5-10mic increments every 3-5 minutes as required and tolerated – max 200mic/min
  • activate cGMP leading to vascular smooth muscle relaxation by sequestration of calcium into the SR
  • At lower doses are primarily venodilators and a venovaso dilators at high doses
  • This improves pump function while reducing o2 demand- added benifit of direct cononary artery dilation reducing risk of ischaemia
  • Tachyphylaxis occurs over hours to days
  • avoid in sidenafil

Loop diuretics
frusemide 40mg IV if naive if take regularly double maitenance dose
- inhibit sodium resoprtion from renal filtrate resulting in significant increase in salt and water excretion.
-in patient with volume overload actions lower plasma volume and pulmonary congestion.
-diuretic affect begins within 10 minutes however symptom relief begins earlier as a result of drug induced neurohumoral changes acting as both vasodilaotr and promiting renal PG2e
-patient without underlying chronic heart failure may have low plasma volumes and diuresiss in this group is unecessary and can lead to complications

28
Q

Discuss treatment of acute heart failure in hypotensive patients

A

Patient with ACPE and apparent systemic hypotension present a therapeutic dilemma . Coronary artery perfusion depend on the pressure gradient between the aorta and the LV in diastole.
The combination of systemic hypotension and elevated left sided pressure dramatically decreases coronary artery perfusion.

Vasopressor use may be required if this constellation truly exists however vasopressores can increase afterload, decrease CO and increased myocardial o2 demand, excerbate ischaemia and precipitate dysrhythmias.

Judicious fluid bolus can be used initially 250 ml over 5-10 minutes if nil respiratory deterioration can be reported- fluid challenge alone will restore perfusing pressure in 50% of cases

In those who have high filling pressure but low cardiac output vasopressors can be used – can be counterproductive in those with acute MI and severe LV dysfunction as they increase mycocadial o2 demand - which may exacerbate ischaemia
Choices incldue
- dobutamine starting at 2.5mcg/kg/min increasing to 20mcg/kg/min as needed
-Milronone (phosphodiesterase inhibitor, increase cardiac contractility and cause vaso,venodilation) - loading dose of 50mcg/kg then 0.375 -0.750 mcg/kg

In hypotensive patients who are adequately volume repleted (true cardiogenic shock) and have appropriate vasopressor support norad is the pressor of choice It raises BP and coronary artery perfusion via alpha affects and has a modest inotrpy and the least overal increase in HR and contractility limiting o2 demand.

EPI has strong beta and alpha activity and can increase myocardial o2 demand. Good at reversing stunned myocardium post surgery

29
Q

Discuss mechanical support option in patient with hypotenseion and evidence of shock with reduced EF failure

A

Entra aortic balloon pump
ECMO
Extracorporeal ventricular assist device

30
Q

Discuss management of chronic heart failure

A
  • ACE inhibitors
  • Beta blockad (long term activation of the sympathetic nervous system, direct cardiotoxcitiy due to elevated NORAD, activation of the RAS and myocardial beta-adrenergic receptor downregulation are all associated with adverse effects)
  • Diuretics
  • Cardiac glycosides

Other considerations

  • IACD
  • Antidysrhytmics
  • CA channel blocakde
  • Renal diaysis
  • CABG
  • Phosphodiesterase inhibtiors - Milrinone
  • statins
31
Q

Describe how aortic balloon pumps work

A

1) the balloon is timed to inflate and deflate in time with cardiac cycle
2) trigger options include
- ECG (using R wave to identify onset of systole) if sinus rhythym
- if paced then pacing spikes can be used
- artieral waveform
- an internal trigger mode is avialable for asytole arrested patients
3) During systole the balloon is deflated which creates suction reducing afterload that the LV needs to overcome to achieve SV
4) During diastole the balloon is inflated - this creates positive pressure within the aorta pushing blood toward the aorta - due to AV valve being closed blood is pushed into the ostium increasing coronary artery flow

32
Q

Describe how LVAD is used

A

Conduit from LV to aorta bypassing LV as pump